GRS Meetings 2010

 

 

Meeting number 57
Date 3/12/2010 à 16h
Topic GRS Symposium: New insights into fundamental and clinical HIV/AIDS research (download poster here)
Organizers Jaques Thèze, Lisa Chakrabarti, Gianfranco Pancino, Livia Pedroza-Martins, Frédéric Tangy
Speakers Françoise BARRE-SINOUSSI
 Unité de Régulation des Infections Rétrovirales, IP, Paris, France
Introduction
Didier TRONO
 Ecole Polytechnique Fédérale de Lausanne, Suisse
Millions of years of retroviral promiscuity:
challenges and opportunities for HIV therapeutics

Rafick SEKALY
 Vaccine and Gene Therapy Institute, Florida, USA
The innate immunity / adaptative immunity interface in HIV Infection

Amalio TELENTI
 Université de Lausanne, Suisse
HIV - Will genomics and systems biology deliver?
Javier MARTINEZ-PICADO
 IrsiCaixa Foundation, Badalona,Spain
Residual HIV replication and therapy intensification

 

Meeting number 56
Date 23/11/2010 à 16h
Topic HIV infection and cancers
Organizers Claudine Duvivier and Jaques Thèze
Speakers Jean-Philippe Spano
 Hôpital Pitié-Salpêtrière, Département d'Oncologie Médicale, Paris
HIV infection and cancers : can recent knowledge in carcinogenesis help improve cancer prevention in HIV infection?
Christophe Piketty
 Hôpital européen Georges Pompidou, service d'Immunologie Clinique, Paris
HIV infection and anal cancer: effect of immune reconstitution under HAART

Antoine Gessain
 Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, Paris
Kaposi sarcoma and HHV8: clinical, pidemiological, and virological aspects; interactions with HIV infection.

 

Meeting number 55
Date 10/05/2010 at noon
Topic GRS European Seminr Series
Organizer Gianfranco Pancino
Speaker Hans-Georg Kräusslich
 Virology department, Heidelberg University
Structure and dynamics of HIV assembly and maturation

 

Meeting number 54
Date 09/14/2010
Topic Th17 lymphocytes in HIV infection
Organizer Marie-Lise Gougeon
Speakers Gérad Eberl
 Unité de Développement des Tissus Lymphoïdes, Institut Pasteur, Paris
Pro-inflammatory innate lymphoid cells
Jérôme Estaquier
 INSERM U955, Faculté de Médecine de Créteil
IL-17and SIV infection models
Mario Clerici
 University of Milan, Italy
Th17 in the phenomenon of resistance to HIV infection

 

Meeting number 53
Date 04/13/2010
Topic Treatment of primary HIV infection
Organizer Lisa Chakrabarti
Discussant Alain Venet
Speakers Pierre Roques
 Service d'Immuno-virologie, IMETI, CEA, Fontenay-au-Roses
Lessons from the SIV/macaque model for the design of treatment strategies for primary HIV infection
Cécile Goujard
 Service de Médecine Interne, Hôpital de Bicêtre, Le Kremlin-Bicêtre
Current trends in the therapy of primary HIV infection
Christine Rouzioux
 Laboratoire de Virologie, CHU Necker-Enfants Malades, Paris
Treatment of primary HIV infection: the virologist perspctive

 

Meeting number 52
Date 03/09/2010
Topic New therapeutic targets against HIV
Organizer Frédéric Tangy
Speakers Françoise Baleux
 Chimie des Biomolécules, Institut Pasteur, Paris
MiniCD4-HS: a new appoach to block HIV entry
Richard Benarous
 CellVir, Pépinière Génopole Entreprise, Evry
HIV-1 integrase cofactors
Sébastien Igonet
 Virologie Structurale, Institut Pasteur, Paris
Structural characterization of a reactive groove in HIV-1 capsid protein defined by assembly inhibitors

 

Meeting number 51
Date 02/09/2010
Topic Mother-to-child HIV-1 transmission: a model for success in prevention?
Organizer Elisabeth Menu
Speakers Francois Dabis
 INSERM U897, ISPED, Université Bordeaux 2, France
Clinical and operational challenges for prevention of mother-to-child transmission in Africa
Mathurin Tejiokem
 Unité d'Epidémiologie, Centre Pasteur du Cameroun, Yaoundé, Cameroon
Mother-to-child HIV transmission in routine practice of PMTCT: recent experience from three referral hospitals in Cameroon
Gabriella Scarlatti
 DIBIT, San Raffaele Scientific Institute, Milan, Italy
Research on HIV-1 mother-to-child transmission to discover correlates of protection